List of Chapters/Sections(Table Of Content)
1 Introduction to Research & Analysis Reports
1.1 Personalized Medicines In Oncology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Personalized Medicines In Oncology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Personalized Medicines In Oncology Overall Market Size
2.1 Global Personalized Medicines In Oncology Market Size: 2021 VS 2028
2.2 Global Personalized Medicines In Oncology Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Personalized Medicines In Oncology Players in Global Market
3.2 Top Global Personalized Medicines In Oncology Companies Ranked by Revenue
3.3 Global Personalized Medicines In Oncology Revenue by Companies
3.4 Top 3 and Top 5 Personalized Medicines In Oncology Companies in Global Market, by Revenue in 2021
3.5 Global Companies Personalized Medicines In Oncology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Personalized Medicines In Oncology Players in Global Market
3.6.1 List of Global Tier 1 Personalized Medicines In Oncology Companies
3.6.2 List of Global Tier 2 and Tier 3 Personalized Medicines In Oncology Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Personalized Medicines In Oncology Market Size Markets, 2021 & 2028
4.1.2 Molecular Oncopathology
4.1.3 Genome Diagnostics
4.1.4 Radiation Therapy
4.1.5 Oncology Testing
4.1.6 Chemotherapy
4.1.7 Others
4.2 By Type - Global Personalized Medicines In Oncology Revenue & Forecasts
4.2.1 By Type - Global Personalized Medicines In Oncology Revenue, 2017-2022
4.2.2 By Type - Global Personalized Medicines In Oncology Revenue, 2023-2028
4.2.3 By Type - Global Personalized Medicines In Oncology Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Personalized Medicines In Oncology Market Size, 2021 & 2028
5.1.2 Research Centers
5.1.3 Governmental Institutions
5.1.4 Hospitals
5.1.5 Clinical Centers
5.1.6 Others
5.2 By Application - Global Personalized Medicines In Oncology Revenue & Forecasts
5.2.1 By Application - Global Personalized Medicines In Oncology Revenue, 2017-2022
5.2.2 By Application - Global Personalized Medicines In Oncology Revenue, 2023-2028
5.2.3 By Application - Global Personalized Medicines In Oncology Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Personalized Medicines In Oncology Market Size, 2021 & 2028
6.2 By Region - Global Personalized Medicines In Oncology Revenue & Forecasts
6.2.1 By Region - Global Personalized Medicines In Oncology Revenue, 2017-2022
6.2.2 By Region - Global Personalized Medicines In Oncology Revenue, 2023-2028
6.2.3 By Region - Global Personalized Medicines In Oncology Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Personalized Medicines In Oncology Revenue, 2017-2028
6.3.2 US Personalized Medicines In Oncology Market Size, 2017-2028
6.3.3 Canada Personalized Medicines In Oncology Market Size, 2017-2028
6.3.4 Mexico Personalized Medicines In Oncology Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Personalized Medicines In Oncology Revenue, 2017-2028
6.4.2 Germany Personalized Medicines In Oncology Market Size, 2017-2028
6.4.3 France Personalized Medicines In Oncology Market Size, 2017-2028
6.4.4 U.K. Personalized Medicines In Oncology Market Size, 2017-2028
6.4.5 Italy Personalized Medicines In Oncology Market Size, 2017-2028
6.4.6 Russia Personalized Medicines In Oncology Market Size, 2017-2028
6.4.7 Nordic Countries Personalized Medicines In Oncology Market Size, 2017-2028
6.4.8 Benelux Personalized Medicines In Oncology Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Personalized Medicines In Oncology Revenue, 2017-2028
6.5.2 China Personalized Medicines In Oncology Market Size, 2017-2028
6.5.3 Japan Personalized Medicines In Oncology Market Size, 2017-2028
6.5.4 South Korea Personalized Medicines In Oncology Market Size, 2017-2028
6.5.5 Southeast Asia Personalized Medicines In Oncology Market Size, 2017-2028
6.5.6 India Personalized Medicines In Oncology Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Personalized Medicines In Oncology Revenue, 2017-2028
6.6.2 Brazil Personalized Medicines In Oncology Market Size, 2017-2028
6.6.3 Argentina Personalized Medicines In Oncology Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Personalized Medicines In Oncology Revenue, 2017-2028
6.7.2 Turkey Personalized Medicines In Oncology Market Size, 2017-2028
6.7.3 Israel Personalized Medicines In Oncology Market Size, 2017-2028
6.7.4 Saudi Arabia Personalized Medicines In Oncology Market Size, 2017-2028
6.7.5 UAE Personalized Medicines In Oncology Market Size, 2017-2028
7 Players Profiles
7.1 Biotheranostics
7.1.1 Biotheranostics Corporate Summary
7.1.2 Biotheranostics Business Overview
7.1.3 Biotheranostics Personalized Medicines In Oncology Major Product Offerings
7.1.4 Biotheranostics Personalized Medicines In Oncology Revenue in Global Market (2017-2022)
7.1.5 Biotheranostics Key News
7.2 Illumina
7.2.1 Illumina Corporate Summary
7.2.2 Illumina Business Overview
7.2.3 Illumina Personalized Medicines In Oncology Major Product Offerings
7.2.4 Illumina Personalized Medicines In Oncology Revenue in Global Market (2017-2022)
7.2.5 Illumina Key News
7.3 DNA Link
7.3.1 DNA Link Corporate Summary
7.3.2 DNA Link Business Overview
7.3.3 DNA Link Personalized Medicines In Oncology Major Product Offerings
7.3.4 DNA Link Personalized Medicines In Oncology Revenue in Global Market (2017-2022)
7.3.5 DNA Link Key News
7.4 Genomic Health, Inc.(Exact Sciences)
7.4.1 Genomic Health, Inc.(Exact Sciences) Corporate Summary
7.4.2 Genomic Health, Inc.(Exact Sciences) Business Overview
7.4.3 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Major Product Offerings
7.4.4 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Revenue in Global Market (2017-2022)
7.4.5 Genomic Health, Inc.(Exact Sciences) Key News
7.5 Cypher Genomics(Human Longevity, Inc.)
7.5.1 Cypher Genomics(Human Longevity, Inc.) Corporate Summary
7.5.2 Cypher Genomics(Human Longevity, Inc.) Business Overview
7.5.3 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Major Product Offerings
7.5.4 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Revenue in Global Market (2017-2022)
7.5.5 Cypher Genomics(Human Longevity, Inc.) Key News
7.6 Life Technologies Corporation(Thermo Fisher Scientific)
7.6.1 Life Technologies Corporation(Thermo Fisher Scientific) Corporate Summary
7.6.2 Life Technologies Corporation(Thermo Fisher Scientific) Business Overview
7.6.3 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Major Product Offerings
7.6.4 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Revenue in Global Market (2017-2022)
7.6.5 Life Technologies Corporation(Thermo Fisher Scientific) Key News
7.7 Fulgent Genetics
7.7.1 Fulgent Genetics Corporate Summary
7.7.2 Fulgent Genetics Business Overview
7.7.3 Fulgent Genetics Personalized Medicines In Oncology Major Product Offerings
7.7.4 Fulgent Genetics Personalized Medicines In Oncology Revenue in Global Market (2017-2022)
7.7.5 Fulgent Genetics Key News
7.8 Caris Life Sciences
7.8.1 Caris Life Sciences Corporate Summary
7.8.2 Caris Life Sciences Business Overview
7.8.3 Caris Life Sciences Personalized Medicines In Oncology Major Product Offerings
7.8.4 Caris Life Sciences Personalized Medicines In Oncology Revenue in Global Market (2017-2022)
7.8.5 Caris Life Sciences Key News
7.9 Ariana Pharma
7.9.1 Ariana Pharma Corporate Summary
7.9.2 Ariana Pharma Business Overview
7.9.3 Ariana Pharma Personalized Medicines In Oncology Major Product Offerings
7.9.4 Ariana Pharma Personalized Medicines In Oncology Revenue in Global Market (2017-2022)
7.9.5 Ariana Pharma Key News
7.10 Abbott Laboratories
7.10.1 Abbott Laboratories Corporate Summary
7.10.2 Abbott Laboratories Business Overview
7.10.3 Abbott Laboratories Personalized Medicines In Oncology Major Product Offerings
7.10.4 Abbott Laboratories Personalized Medicines In Oncology Revenue in Global Market (2017-2022)
7.10.5 Abbott Laboratories Key News
7.11 deCODE genetics
7.11.1 deCODE genetics Corporate Summary
7.11.2 deCODE genetics Business Overview
7.11.3 deCODE genetics Personalized Medicines In Oncology Major Product Offerings
7.11.4 deCODE genetics Personalized Medicines In Oncology Revenue in Global Market (2017-2022)
7.11.5 deCODE genetics Key News
7.12 Exagen Inc
7.12.1 Exagen Inc Corporate Summary
7.12.2 Exagen Inc Business Overview
7.12.3 Exagen Inc Personalized Medicines In Oncology Major Product Offerings
7.12.4 Exagen Inc Personalized Medicines In Oncology Revenue in Global Market (2017-2022)
7.12.5 Exagen Inc Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
